Insider Trading & Ownership - Henderson Molly

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Henderson Molly
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-04-08
Sale
2024-04-10
4:30 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
3,435$11.1$38,12997,174
(Indirect
Direct)
View
2024-01-19
Sale
2024-01-22
8:22 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
6,307$7.7533$48,900220,609
(Indirect
Direct)
View
2023-11-20
Sale
2023-11-21
4:40 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
2,127$7.2415$15,403104,195
(Indirect
Direct)
View
2023-11-01
Sale
2023-11-03
4:55 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
12,492$8.8753$110,871106,322
(Indirect
Direct)
View
2023-06-02
Sale
2023-06-05
6:32 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
1,960$11.41$22,36868,845
(Indirect
Direct)
View
2023-05-22
Sale
2023-05-23
12:15 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
2,110$12.87$27,16570,805
(Indirect
Direct)
View
2023-04-06
Sale
2023-04-07
3:18 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
3,439$7.27$25,00272,915
(Indirect
Direct)
View
2023-03-01
Sale
2023-03-03
7:03 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
2,032$8.5309$17,33576,354
(Indirect
Direct)
View
2022-11-21
Sale
2022-11-23
4:10 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
2,159$9.6$20,72643,680
(Indirect
Direct)
View
2022-05-13
Purchase
2022-05-16
8:43 pm
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
6,000$0$026,000
(Direct)
View
2022-01-31
Sale
2022-02-02
4:34 pm
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
331$7.58$2,50944,082
(Direct)
View
2021-11-30
Sale
2021-12-02
1:15 pm
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
2,587$12.03$31,12214,913
(Direct)
View
2021-05-17
Purchase
2021-05-18
11:36 am
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
2,500$15.85$39,6252,500
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-18
Option Award
2024-01-22
8:22 pm
N/A
2034-01-17
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
120,000$0220,609
(Direct)
View
2023-11-01
Option Award
2023-11-03
4:55 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
22,500$0106,322
(Direct)
View
2023-07-14
Option Award(A)
2023-07-21
8:30 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
25,000$095,180
(Direct)
View
2023-07-14
Option Award
2023-07-17
5:00 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
25,000$196,314
(Direct)
View
2023-01-19
Option Award
2023-01-20
7:32 pm
N/A
2033-01-18
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
88,000$0133,386
(Direct)
View
2022-09-01
Option Award
2022-09-02
4:05 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
7,500$045,839
(Direct)
View
2022-05-19
Option Award
2022-05-20
5:17 pm
N/A
N/A
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
12,000$038,000
(Direct)
View
2022-04-05
Option Award
2022-04-06
8:50 pm
N/A
2032-04-04
Phathom Pharmaceuticals Inc.PHATHenderson Molly
CFO and CBO
120,000$0120,000
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:34 pm
N/A
N/A
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
37,500$044,082
(Direct)
View
2022-01-31
Exercise
2022-02-02
4:34 pm
N/A
N/A
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
666$044,082
(Direct)
View
2021-11-30
Exercise
2021-12-02
1:15 pm
N/A
N/A
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
5,000$014,913
(Direct)
View
2021-06-05
Option Award
2021-06-08
2:33 pm
N/A
2031-05-31
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
15,000$015,000
(Direct)
View
2021-01-31
Option Award
2021-02-02
3:57 pm
N/A
2031-01-30
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
8,000$08,000
(Direct)
View
2020-10-01
Option Award
2020-10-05
4:37 pm
N/A
2030-09-30
UroGen Pharma Ltd.URGNHenderson Molly
Chief Financial Officer
75,000$075,000
(Direct)
View
2020-05-04
Option Award
2020-05-05
4:00 pm
N/A
2030-05-04
Advaxis Inc.ADXSHenderson Molly
Executive Vice President & CFO
50,000$050,000
(Direct)
View
2019-10-24
Option Award
2019-10-25
4:30 pm
2020-10-24
2029-10-24
Advaxis Inc.ADXSHenderson Molly
Executive Vice President & CFO
25,000$025,000
(Direct)
View
(A) Indicate amendment filing.